Vivity complements Alcon’s existing IOL portfolio by providing an additional option for cataract patients to treat presbyopia A first-of-its-kind, non-diffractive lens that offers a continuous ...

TORONTO, Nov. 17, 2020 /CNW/ - Alcon, the global leader in eye care, is pleased to announce the Canadian launch of AcrySof ® IQ Vivity ®, a first-of-its-kind, surgical lens designed to help cataract ...

Please provide your email address to receive an email when new articles are posted on . WAILEA, Hawaii — The AcrySof IQ Vivity IOL features less glare and fewer halos with “significantly fewer ...

Alcon ALC recently announced that its Clareon Vivity intraocular lens (IOL), featuring extended depth of focus (EDOF) technology, has received CE Mark approval. The lens, made from Alcon's advanced ...

FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity ...

Two specialists at Phoenix-based Valley Eye Specialists were among the first group of surgeons in the nation to implant the Alcon Acrysof IQ Vivity Lens after FDA approval, according to a Feb. 1 news ...

Please provide your email address to receive an email when new articles are posted on . VIENNA — In this Healio Video Perspective from the ESCRS meeting, Nic Reus, MD, presents the results of a ...

Alcon ALC unveiled the final data from its Vivity Registry study, marking a significant milestone in the company's progress within its Surgical franchise. This study tracked real-world patient ...

GENEVA--(BUSINESS WIRE)-- Regulatory News: Alcon (SIX/NYSE:ALC), the global leader in eye care announced AcrySof® IQ Vivity®, a first-of-its-kind intraocular lens (IOL) is now commercially available ...